| For: | Söderberg-Nauclér C, Johnsen JI. Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options. World J Exp Med 2015; 5(1): 1-10 [PMID: 25699229 DOI: 10.5493/wjem.v5.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315X/full/v5/i1/1.htm |
| Number | Citing Articles |
| 1 |
Natalia E. Fedorova, Yana Yu Chernoryzh, Galina R. Vinogradskaya, Svetlana S. Emelianova, Larisa E. Zavalyshina, Kirill I. Yurlov, Natalia F. Zakirova, Valery N. Verbenko, Sergey N. Kochetkov, Alla A. Kushch, Alexander V. Ivanov. Inhibitor of polyamine catabolism MDL72.527 restores the sensitivity to doxorubicin of monocytic leukemia Thp-1 cells infected with human cytomegalovirus. Biochimie 2019; 158 doi: 10.1016/j.biochi.2018.12.012
|
| 2 |
Paul W. Ewald, Holly A. Swain Ewald. The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective. Philosophical Transactions of the Royal Society B: Biological Sciences 2019; 374(1773) doi: 10.1098/rstb.2018.0304
|
| 3 |
John H. Sampson, Duane A. Mitchell. Vaccination strategies for neuro-oncology: Table 1.. Neuro-Oncology 2015; 17(suppl 7) doi: 10.1093/neuonc/nov159
|
| 4 |
Juliana Noguti, Delphine J. Lee. Microbiome and Cancer. Current Cancer Research 2019; doi: 10.1007/978-3-030-04155-7_7
|
| 5 |
Cecilia Söderberg Nauclér, Jürgen Geisler, Katja Vetvik. The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications. Oncotarget 2019; 10(42) doi: 10.18632/oncotarget.27016
|
| 6 |
S. Harrison Farber, Aladine A. Elsamadicy, Ahmet Fatih Atik, Carter M. Suryadevara, Pakawat Chongsathidkiet, Peter E. Fecci, John H. Sampson. The Safety of available immunotherapy for the treatment of glioblastoma. Expert Opinion on Drug Safety 2017; 16(3) doi: 10.1080/14740338.2017.1273898
|
| 7 |
Angelique Flöter Rådestad, Atosa Estekizadeh, Huanhuan L Cui, Ourania N. Kostopoulou, Belghis Davoudi, Angelica Lindén Hirschberg, Joseph Carlson, Afsar Rahbar, Cecilia Söderberg-Naucler. Impact of Human Cytomegalovirus Infection and its Immune Response on Survival of Patients with Ovarian Cancer. Translational Oncology 2018; 11(6) doi: 10.1016/j.tranon.2018.08.003
|
| 8 |
Bogdan Ionel Vatu, Stefan-Alexandru Artene, Adeline-Georgiana Staicu, Adina Turcu-Stiolica, Catalin Folcuti, Alexandra Dragoi, Catalina Cioc, Stefania-Carina Baloi, Ligia Gabriela Tataranu, Cristian Silosi, Anica Dricu. Assessment of efficacy of dendritic cell therapy and viral therapy in high grade glioma clinical trials. A meta-analytic review. Journal of Immunoassay and Immunochemistry 2019; 40(1) doi: 10.1080/15321819.2018.1551804
|
| 9 |
Olasunmbo O. Okedele, Heather H. Nelson, Mosun L. Oyenuga, Bharat Thyagarajan, Anna Prizment. Cytomegalovirus and cancer-related mortality in the national health and nutritional examination survey. Cancer Causes & Control 2020; 31(6) doi: 10.1007/s10552-020-01296-y
|
| 10 |
Li Li, Lili Kong, Lili Liu, Huimin Li, Yibo Lu, Meiji Ren, Zhao Liu, Liwei Fu, Xuhua Yang, Yupeng Liu. Radiology of Infectious and Inflammatory Diseases - Volume 3. 2023; doi: 10.1007/978-981-99-4614-3_17
|
| 11 |
Sudipta Pathak, Jacek R. Wilczyński, Edyta Paradowska. Factors in Oncogenesis: Viral Infections in Ovarian Cancer. Cancers 2020; 12(3) doi: 10.3390/cancers12030561
|
| 12 |
Travis S. Johnson, Zachary B. Abrams, Xiaokui Mo, Yan Zhang, Kun Huang. Lack of human cytomegalovirus expression in single cells from glioblastoma tumors and cell lines. Journal of NeuroVirology 2017; 23(5) doi: 10.1007/s13365-017-0543-y
|
| 13 |
David Navarro. Expanding role of cytomegalovirus as a human pathogen. Journal of Medical Virology 2016; 88(7) doi: 10.1002/jmv.24450
|
| 14 |
Helga Rübsamen‐Schaeff. New Drug Development for Known and Emerging Viruses. Methods and Principles in Medicinal Chemistry 2022; doi: 10.1002/9783527810697.ch6
|
| 15 |
Katelyn D. Miller, Christine M. Matullo, Katelynn A. Milora, Riley M. Williams, Kevin J. O’Regan, Glenn F. Rall, Stacey Schultz-Cherry. Immune-Mediated Control of a Dormant Neurotropic RNA Virus Infection. Journal of Virology 2019; 93(18) doi: 10.1128/JVI.00241-19
|
| 16 |
Maria F De la Cerda-Vargas, Jens Schittenhelm, Martin Ebinger, Julian Zipfel, Rudi Beschorner, Ghazaleh Tabatabai, Martin U Schuhmann. High human cytomegalovirus antigen expression in pediatric medulloblastoma tissue is associated with poor event-free survival. Neuro-Oncology Advances 2026; 8(1) doi: 10.1093/noajnl/vdaf266
|
| 17 |
L.A. Colby, E. Corwin. Patient Derived Tumor Xenograft Models. 2017; doi: 10.1016/B978-0-12-804010-2.00014-X
|
| 18 |
Tianrui Yang, Delin Liu, Shiyuan Fang, Wenbin Ma, Yu Wang. Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies. Journal of Clinical Medicine 2022; 11(17) doi: 10.3390/jcm11175221
|
| 19 |
Marco Zeppieri, Caterina Gagliano, Daniele Tognetto, Fabiana D’Esposito, Babatunde Ismail Bale, Ekele Chukwuyem, Gladness Aluyi-Osa, Mutali Musa. Eye on cytomegalovirus: Unveiling the ophthalmic impact of cytomegalovirus. World Journal of Virology 2025; 14(2): 101944 doi: 10.5501/wjv.v14.i2.101944
|
| 20 |
Russell L. Blaylock. Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment. Surgical Neurology International 2019; 10 doi: 10.25259/SNI_361_2019
|
| 21 |
Ariana Pritha, Richard Anderson, David E Anderson, Theodore Nicolaides. A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma. Cureus 2022; doi: 10.7759/cureus.23447
|
| 22 |
Nadia Mensali, Else Marit Inderberg. Emerging Biomarkers for Immunotherapy in Glioblastoma. Cancers 2022; 14(8) doi: 10.3390/cancers14081940
|
| 23 |
Stefan-Alexandru Artene, Adina Turcu-Stiolica, Marius Eugen Ciurea, Catalin Folcuti, Ligia Gabriela Tataranu, Oana Alexandru, Oana Stefana Purcaru, Daniela Elise Tache, Mihail Virgil Boldeanu, Cristian Silosi, Anica Dricu. Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30296-x
|
| 24 |
Jiri Bartek, Joanna M. Merchut-Maya, Apolinar Maya-Mendoza, Olesja Fornara, Afsar Rahbar, Christian Beltoft Bröchner, Astrid Sehested, Cecilia Söderberg-Nauclér, Jiri Bartek, Jirina Bartkova. Cancer cell stemness, responses to experimental genotoxic treatments, cytomegalovirus protein expression and DNA replication stress in pediatric medulloblastomas. Cell Cycle 2020; 19(7) doi: 10.1080/15384101.2020.1728025
|
| 25 |
Jason Buehler, Sebastian Zeltzer, Justin Reitsma, Alex Petrucelli, Mahadevaiah Umashankar, Mike Rak, Patricia Zagallo, Joyce Schroeder, Scott Terhune, Felicia Goodrum, Andrew Yurochko. Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication. PLOS Pathogens 2016; 12(5) doi: 10.1371/journal.ppat.1005655
|
| 26 |
Elizabeth C. Delery, Andrew G. MacLean. Chronic Viral Neuroinflammation: Speculation on Underlying Mechanisms. Viral Immunology 2019; 32(1) doi: 10.1089/vim.2018.0093
|
| 27 |
Katelyn D. Miller, Matthias J. Schnell, Glenn F. Rall. Keeping it in check: chronic viral infection and antiviral immunity in the brain. Nature Reviews Neuroscience 2016; 17(12) doi: 10.1038/nrn.2016.140
|
| 28 |
Julius W. Kim, J. Robert Kane, Wojciech K. Panek, Jacob S. Young, Aida Rashidi, Dou Yu, Deepak Kanojia, Tanwir Hasan, Jason Miska, Miguel A. Gómez-Lim, Ilya V. Ulasov, Irina V. Balyasnikova, Atique U. Ahmed, Derek A. Wainwright, Maciej S. Lesniak. A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics 2018; 15(4) doi: 10.1007/s13311-018-0650-3
|
| 29 |
Jiri Bartek, Olesja Fornara, Joanna Maria Merchut‐Maya, Apolinar Maya‐Mendoza, Afshar Rahbar, Giuseppe Stragliotto, Helle Broholm, Mikael Svensson, Astrid Sehested, Cecilia Söderberg Naucler, Jiri Bartek, Jirina Bartkova. Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas. Molecular Oncology 2017; 11(8) doi: 10.1002/1878-0261.12061
|
| 30 |
Cecilia Söderberg-Nauclér, Olesja Fornara, Afsar Rahbar. Cytomegalovirus driven immunosenescence—An immune phenotype with or without clinical impact?. Mechanisms of Ageing and Development 2016; 158 doi: 10.1016/j.mad.2016.06.005
|
| 31 |
Sergio Zavala-Vega, Graciela Castro-Escarpulli, Hector Hernández-Santos, Citlatepetl Salinas-Lara, Icela Palma, Juan Manuel Mejía-Aranguré, Noemí Gelista-Herrera, Daniel Rembao-Bojorquez, Sara A. Ochoa, Ariadnna Cruz-Córdova, Juan Xicohtencatl-Cortes, Gabriel Uribe-Gutiérrez, José Arellano-Galindo. An overview of the infection of CMV, HSV 1/2 and EBV in Mexican patients with glioblastoma multiforme. Pathology - Research and Practice 2017; 213(3) doi: 10.1016/j.prp.2016.12.006
|
| 32 |
Ching-Fen Yang, Hsiang-Ling Ho, Shih-Chieh Lin, Chih-Yi Hsu, Donald Ming-Tak Ho, Michael Nevels. Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects. PLOS ONE 2017; 12(6) doi: 10.1371/journal.pone.0179366
|
| 33 |
Sylvia C. Kurz, Patrick Y. Wen. Quo Vadis—Do Immunotherapies Have a Role in Glioblastoma?. Current Treatment Options in Neurology 2018; 20(5) doi: 10.1007/s11940-018-0499-0
|
| 34 |
Xiaohui Xie, Mengyuan Yang, Yiling Ding, Jianlin Chen. Microbial infection, inflammation and epithelial ovarian cancer. Oncology Letters 2017; 14(2) doi: 10.3892/ol.2017.6388
|
| 35 |
Alejandro M. Hortal, Jeroen F. Vermeulen, Wim Van Hecke, Niels Bovenschen. Oncogenic role of cytomegalovirus in medulloblastoma?. Cancer Letters 2017; 408 doi: 10.1016/j.canlet.2017.08.024
|